Flarin Holdings Ltd owns infirst Ltd, which focuses exclusively on the rapid commercialisation and globalisation of Flarin® (patent protected lipid formulation of ibuprofen). Flarin® is the first and only OTC lipid formulated ibuprofen clinically proven to be as effective as prescription-strength ibuprofen – without a prescription1. It is indicated for a wide range of symptoms including relief of rheumatic pain or muscular pain, back pain and the pain of non-serious arthritic conditions caused by swelling, stiffness and inflammation.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Central Point, 45 Beech Street,united Kingdom
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.flarinholdings.com
- Keywords
- Cycle Pharmaceuticals.
- HQ
- London, UK
Flarin Holdings Ltd Questions
Flarin Holdings Ltd's website is https://www.flarinholdings.com
Flarin Holdings Ltd's LinkedIn profile is https://uk.linkedin.com/company/flarin-holdings-ltd
Flarin Holdings Ltd has
3 employees.
View email and phone details for 3
employees at Flarin Holdings Ltd.
Flarin Holdings Ltd's industry is
Pharmaceutical Manufacturing
Flarin Holdings Ltd's top competitors are
Flarin,
Cycle Pharmaceuticals,
Infirst Ltd,
Infirst Healthcare,
Trisalta Gmbh - Rare Disease Biopharma Consulting,
Seek Group (Peptcell Limited),
Vanda Pharmaceuticals.
Flarin Holdings Ltd's categories are Pharmaceutical Manufacturing
Flarin Holdings Ltd's founding year is 2019
